Home » ASPENBIO PHARMA ANNOUNCES RECENT DEVELOPMENTS REGARDING HUMAN APPENDICITIS TEST
ASPENBIO PHARMA ANNOUNCES RECENT DEVELOPMENTS REGARDING HUMAN APPENDICITIS TEST
AspenBio Pharma announced that its U.S. and international patent applications
entitled "Methods and devices for diagnosis of appendicitis" have
recently been published by the United States Patent Office and the International
Bureau of the World Intellectual Property Organization. AspenBio has also recently
filed a further separate patent application seeking to expand its worldwide
position of intellectual property protection associated with this technology.
PR
Newswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May